These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16749531)

  • 1. Impurities in a lyophilized formulation of BMS-204352: identification and role of sanitizing agents.
    Nassar MN; Nesarikar VV; Khaselev N; Lozano R
    Pharm Dev Technol; 2006; 11(2):207-11. PubMed ID: 16749531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures.
    Nassar MN; Nesarikar VV; Lozano R; Huang Y; Palaniswamy V
    Pharm Dev Technol; 2005; 10(2):227-32. PubMed ID: 15926671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleaning validation 1: development and validation of a chromatographic method for the detection of traces of LpHse detergent.
    Zayas J; Colón H; Garced O; Ramos LM
    J Pharm Biomed Anal; 2006 May; 41(2):589-93. PubMed ID: 16406440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of protein by vaporized sanitizing agents.
    Wang W; Cui TY; Wang YJ; Martin-Moe S
    PDA J Pharm Sci Technol; 2004; 58(3):121-9. PubMed ID: 15233252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-laboratory validation of a method for the determination of phenols and phenates in disinfectant formulations by liquid chromatography with UV detection.
    Phillips T; Burns A; McManus K; Bontoyan W
    J AOAC Int; 2010; 93(3):1039-45. PubMed ID: 20629411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
    Nassar MN; Nesarikar VN; Lozano R; Parker WL; Huang Y; Palaniswamy V; Xu W; Khaselev N
    Pharm Dev Technol; 2004; 9(2):189-95. PubMed ID: 15202578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of phenolic disinfectant agents in commercial formulations by liquid chromatography.
    Thompson RD
    J AOAC Int; 2001; 84(3):815-22. PubMed ID: 11417646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the impurities in
    Ma X; Jin L; Li Y; Zheng H; Wei Y
    Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9.
    Jonkman-de Vries JD; Talsma H; Henrar RE; Kettenes-van den Bosch JJ; Bult A; Beijnen JH
    Cancer Chemother Pharmacol; 1994; 34(5):416-22. PubMed ID: 8070009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Levels of Rubber Stopper-Related Organic Leachables in Commercially Available Vialed Liquid and Lyophilized Drug Products.
    Zdravkovic SA
    Pharm Res; 2020 Mar; 37(4):76. PubMed ID: 32232571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between liquid chromatography-UV detection and liquid chromatography-mass spectrometry for the characterization of impurities and/or degradants present in trimethoprim tablets.
    Barbarin N; Henion JD; Wu Y
    J Chromatogr A; 2002 Sep; 970(1-2):141-54. PubMed ID: 12350089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gentamicin impurities by liquid chromatography tandem mass spectrometry.
    Grahek R; Zupancic-Kralj L
    J Pharm Biomed Anal; 2009 Dec; 50(5):1037-43. PubMed ID: 19577403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
    Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of new impurities in zopiclone tablets by LC-QTOF-MS.
    Han X; Cheng FJ; Di B; Xu H; Song M; Hang TJ; Lu YT
    J Pharm Biomed Anal; 2021 May; 199():114056. PubMed ID: 33831736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impurity analysis and quality evaluation for commercial levofloxacin formulations using LC-MS/MS method].
    Zheng YJ; Zhang RP; Gao Y; Wang YC; Wang JX; He JM; Abliz Z
    Yao Xue Xue Bao; 2016 Mar; 51(3):444-9. PubMed ID: 29859027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.